SWOT Analysis for MediCaps Ltd.

Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Month
Company with No Debt
Book Value per share Improving for last 2 years
Company with Zero Promoter Pledge
Stock with Low PE (PE < = 10)
Top Gainers

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Degrowth in Revenue and Profit
Annual net profit declining for last 2 years
Fall in Quarterly Revenue and Net Profit (YoY)
Near 52 Week Low
Weak Momentum: Price below Short, Medium and Long Term Averages
Profit to Loss Companies
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
Increasing Trend in Non-Core Income
Near 52 Week Low
Stocks Underperforming their Industry Price Change in the Quarter